⌘K

Login Start Free

Home/Filings/4/A/0001127602-13-002451

4/A//SEC Filing

Endicott David J. 4/A

Accession 0001127602-13-002451

CIK 0000850693other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 6:40 PM ET

Size

14.6 KB

Accession

0001127602-13-002451

Insider Transaction Report

Form 4/AAmended

Period: 2012-11-29

ALLERGAN INCAGN

Endicott David J.

CVP and President, AGN Med US

Transactions

Exercise/Conversion
Common Stock
2012-11-29$64.47/sh+100$6,447→ 20,452 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-11-29−100→ 1,840 total
Exercise: $64.47Exp: 2018-02-14→ Common Stock (100 underlying)
Exercise/Conversion
Common Stock
2012-11-29$64.47/sh+1,840$118,625→ 22,292 total
Sale
Common Stock
2012-11-29$92.27/sh−100$9,227→ 22,192 total
Sale
Common Stock
2012-11-29$92.33/sh−1,840$169,888→ 20,352 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-11-29−1,840→ 0 total
Exercise: $64.47Exp: 2018-02-14→ Common Stock (1,840 underlying)

Holdings

Common Stock
(indirect: By Trust)
0
Common Stock
(indirect: By Trust)
3,111.907

Footnotes (3)

[F1]Shares allocated to reporting person's SIP account as of reporting date.
[F2]Shares allocated to the reporting person's ESOP account as of reporting date.
[F3]The option became exercisable in four equal annual installments beginning February 14, 2009.

Documents

1 file

4
form4a.xml
PRIMARY DOCUMENT

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeother

Related Parties

1

filerCIK 0001532133

Filing Metadata

Form type: 4/A
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 6:40 PM ET
Size: 14.6 KB

View on SEC.gov